Pediatric endocrinology

Growth Without Growth Hormone in Sellar Germ Cell Tumors: Clinical Characteristics and Predictive Factors

Endocr PractPublished Retrospective case-control study

Authors' conclusion

GWGH occurs in 11.5% of children with sellar GCTs and GHD and is associated with hypothalamic involvement, obesity, and hyperinsulinemia. Elevated fasting insulin may partly explain GWGH, but prospective studies are needed to clarify the underlying mechanisms.

Study context

Population
Children with sellar germ cell tumors (GCTs) and growth hormone deficiency (GHD), with hypogonadotropic hypogonadism or prepubertal status, July 2021–December 2024
Participants
130 children
Comparison
Growth without growth hormone (GWGH) vs non-GWGH
  • GWGHn = 15
Outcome
Clinical features and predictors of GWGH
Methodological detailssingle-centre, 1:2 age- and sex-matched controls
  • Single-centre
  • 1:2 age- and sex-matched controls

Main finding

As reported in the abstract

GWGH prevalence

15

11.5%

Observational data: associations, not effects.

Further findings

Fasting insulin · higher with GWGH

P < 0.001

Pituitary dysfunction and hormone replacement therapy

Did not differ significantly between groups

Original publication

Growth Without Growth Hormone in Sellar Germ Cell Tumors: Clinical Characteristics and Predictive Factors. Endocr Pract. Published 17 December 2025. doi:10.1016/j.eprac.2025.12.006

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.